TNFRSF17 and Miyoshi myopathy: AMG420 (BI-836909) is a novel BiTE that targets both CD3 on T cells and BCMA on MM cells concomitantly to induce MM cell lysis via the cytokine release, such as perforin and granzyme B by activated T cells [87,88].